Kidney Cancer Immunotherapy
Studies by R. Passalacqua and co-authors describe new findings in kidney cancer immunotherapy
Published in Clinical Oncology Week, March 8th, 2010
A new study, 'Phase III, randomised, multicentre trial of maintenance immunotherapy with low-dose interleukin-2 and interferon-alpha for metastatic renal cell cancer,' is now available. According to recent research from Cremona, Italy, "This is the first phase III randomised trial to evaluate maintenance immunotherapy in metastatic renal cell cancer (mRCC). Patients were randomised to receive treatment with a 4-week cycle of subcutaneous low doses IL-2 + IFN in months 1, 3 and 5, and then every 3 months until the first documented disease progression (arm A, suspension), or the same regimen, with chronic maintenance of immunotherapy, regardless of tumor response, until death or intolerable...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- American Cancer Society
Survey finds significant racial differences in lung cancer beliefs - American Cancer Society
Testosterone deficiency affects male cancer survivors' quality of life - American College of Radiology / American Roentgen Ray Society
MRI: Noninvasive diagnostic tool for diagnosing testicular cancer - American Gastroenterological Association
Reliable biomarkers needed for early detection of liver cancer - American Gastroenterological Association
Those who have colonoscopy performed by GIs less likely to develop colorectal cancer - Cold Spring Harbor Laboratory
Melanoma transcriptome reveals novel genomic alterations not seen before - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
